A multicenter matched case control study of breast cancer risk factors among women in Karachi, Pakistan.
Community Health Sciences
Breast cancer (BC), the most common female cancer in Pakistan, is associated with a very high mortality. However, the roles of individual risk factors for BC among Pakistani women are still controversial. To assess potential risk factors for BC, a matched case-control study was conducted in two tertiary care hospitals of Karachi, Pakistan.
MATERIALS AND METHODS:
The study population included 297 pathologically confirmed incident cases of BC patients diagnosed between January 2009 and December 2010. 586 controls without any history of BC were matched on a hospital basis, within 5 years of patient ages.
Family history of BC (MOR=1.72; 95%CI: 1.10, 2.80 for first degree vs. none), single marital status (MOR=1.55; 95%CI: 1.10, 2.39 for single women vs. married women), older age at menopause (MOR=3.92; 95%CI: 2.52, 6.18 for menopausal women aged below 45 years, MOR=6.42; 95%CI: 3.47, 11.98 for menopausal women above 45 years of age compared with premenopausal women) conferred an increased risk of BC for women. Increasing parity decreased the risk of BC (MOR=0.90; 95%CI: 0.85, 0.97 for each live birth). Intake of Vitamin D supplements (MOR=0.30; 95%CI: 0.12, 0.81 for <3 years and MOR=0.27; 95%CI: 0.13, 0.56 for >3 years) was protective compared to non-users of Vitamin D.
This study confirmed only few of the recognized risk factors in Pakistani women. The protective effect of Vitamin D is important from public health perspective and needs to be further explored through a randomized controlled trial.
Publication ( Name of Journal)
Asian Pacific Journal of Cancer Prevention
Syed, I. A.
(2013). A multicenter matched case control study of breast cancer risk factors among women in Karachi, Pakistan.. Asian Pacific Journal of Cancer Prevention, 14(1), 183-188.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_chs_chs/242
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.